{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:56:40Z","timestamp":1786985800591,"version":"build-2736575974"},"reference-count":165,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ccl.2012.04.007","type":"journal-article","created":{"date-parts":[[2012,6,5]],"date-time":"2012-06-05T11:06:44Z","timestamp":1338894404000},"page":"463-491","source":"Crossref","is-referenced-by-count":29,"title":["Cardiovascular Drugs in Pregnancy"],"prefix":"10.1016","volume":"30","author":[{"given":"William H.","family":"Frishman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Elkayam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccl.2012.04.007_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2165\/00003088-199733050-00002","article-title":"Pharmacokinetic changes during pregnancy and their clinical relevance","volume":"33","author":"Loebstein","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ccl.2012.04.007_bib2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/gut.7.6.612","article-title":"Effects of oestrogens and progestogens on gastric secretion in patients with duodenal ulcer","volume":"7","author":"Parbhoo","year":"1966","journal-title":"Gut"},{"key":"10.1016\/j.ccl.2012.04.007_bib3","series-title":"Pharmacokinetic basis for drug treatment","article-title":"Effects of pregnancy on pharmacokinetics","author":"Parker","year":"1984"},{"key":"10.1016\/j.ccl.2012.04.007_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.crd.0000102420.62200.e1","article-title":"Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation","volume":"12","author":"Qasqas","year":"2004","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.ccl.2012.04.007_bib5","series-title":"Drug prescribing in pregnancy","author":"Krauer","year":"1984"},{"key":"10.1016\/j.ccl.2012.04.007_bib6","series-title":"Medical complications during pregnancy","year":"1999"},{"key":"10.1016\/j.ccl.2012.04.007_bib7","series-title":"Burwell and Metcalfe's heart disease and pregnancy: physiology and management","author":"Metcalfe","year":"1986"},{"key":"10.1016\/j.ccl.2012.04.007_bib8","first-page":"37","article-title":"Normal cardiopulmonary adjustments to pregnancy: cardiovascular evaluation","volume":"19","author":"Cole","year":"1989","journal-title":"Cardiovasc Clin"},{"key":"10.1016\/j.ccl.2012.04.007_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000457284","article-title":"Drug binding to plasma proteins during human pregnancy and in the perinatal period. Studies on cloxacillin and alprenolol","volume":"6","author":"Herngren","year":"1983","journal-title":"Dev Pharmacol Ther"},{"key":"10.1016\/j.ccl.2012.04.007_bib10","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/clpt.1981.73","article-title":"Changes in plasma drug binding and a1-acid glycoprotein in mother and newborn infant","volume":"29","author":"Wood","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ccl.2012.04.007_bib11","series-title":"Anesthesia for obstetrics","first-page":"50","article-title":"Perinatal pharmacology","author":"Ralston","year":"1987"},{"key":"10.1016\/j.ccl.2012.04.007_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/0003-4819-98-4-487","article-title":"Antiarrhythmic drug therapy during pregnancy","volume":"98","author":"Rotmensch","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccl.2012.04.007_bib13","series-title":"Cardiac problems in pregnancy","first-page":"3","article-title":"Hemodynamics and cardiac function during normal pregnancy and the puerperium","author":"Elkayam","year":"1998"},{"key":"10.1016\/j.ccl.2012.04.007_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-0528.1981.tb00929.x","article-title":"Serial changes in renal haemodynamics during normal human pregnancy","volume":"88","author":"Dunlop","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0009-9236(97)90118-1","article-title":"Induction of CYP2D6 in pregnancy","volume":"62","author":"Wadelius","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 5","key":"10.1016\/j.ccl.2012.04.007_bib16","first-page":"9S","article-title":"Pharmacokinetics of fetal and neonatal exposure to drugs","volume":"58","author":"Levy","year":"1981","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib17","first-page":"81","article-title":"Congenital rhabdomyoma of the heart and intrauterine digitalis poisoning","volume":"11","author":"Potondi","year":"1967","journal-title":"J\u00a0Forensic Sci"},{"key":"10.1016\/j.ccl.2012.04.007_bib18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3181\/00379727-80-19682","article-title":"Placental transfer of radioactive digitoxin in rats and guinea pigs","volume":"80","author":"Okita","year":"1952","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.ccl.2012.04.007_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0773.1980.tb02454.x","article-title":"Placental transmission and foetal distribution of 3H-ouabain","volume":"46","author":"Saarikoski","year":"1980","journal-title":"Acta Pharmacol Toxicol"},{"key":"10.1016\/j.ccl.2012.04.007_bib20","series-title":"Cardiac problems in pregnancy","first-page":"426","article-title":"Digitalis glycosides in pregnancy","author":"Steinberg","year":"1998"},{"key":"10.1016\/j.ccl.2012.04.007_bib21","series-title":"Cardiovascular pharmacotherapeutics","first-page":"519","article-title":"Pediatric cardiovascular pharmacology","author":"Gewitz","year":"2011"},{"key":"10.1016\/j.ccl.2012.04.007_bib22","first-page":"730","article-title":"Fetal supraventricular tachycardia in utero therapy with digoxin and quinidine","volume":"64","author":"Spinnato","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0002-9149(87)90823-X","article-title":"Association of atrial flutter with orthodromic reciprocating fetal tachycardia","volume":"59","author":"Johnson","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2012.04.007_bib24","series-title":"Manual of medical therapeutics","first-page":"15","article-title":"Pregnancy and medical therapeutics","author":"Whelan","year":"1995"},{"key":"10.1016\/j.ccl.2012.04.007_bib25","series-title":"Cardiac problems in pregnancy","first-page":"373","article-title":"Antiarrhythmic drugs during pregnancy and lactation","author":"Shotan","year":"1998"},{"key":"10.1016\/j.ccl.2012.04.007_bib26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1185\/03007997909109400","article-title":"Disopyramide in pregnancy: a case report","volume":"6","author":"Shaxted","year":"1979","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ccl.2012.04.007_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000542-197806000-00006","article-title":"Placental transfer of lidocaine: effects of fetal acidosis","volume":"48","author":"Biehl","year":"1978","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ccl.2012.04.007_bib28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000542-198908000-00024","article-title":"Continuous epidural lidocaine infusion in the parturient with paroxysmal ventricular tachycardia","volume":"71","author":"Juneja","year":"1989","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ccl.2012.04.007_bib29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00000542-197009000-00006","article-title":"Binding of anilide-type local anesthetics in human plasma. II. Implications in\u00a0vivo, with special reference to transplacental distribution","volume":"33","author":"Tucker","year":"1970","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ccl.2012.04.007_bib30","first-page":"33","article-title":"Mexiletine use in pregnancy","volume":"8","author":"Gregg","year":"1988","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.ccl.2012.04.007_bib31","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0002-9378(87)80191-6","article-title":"Mexiletine use in pregnancy and lactation","volume":"157","author":"Lownes","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/hrt.67.3.266","article-title":"Incessant atrial tachycardia accelerated by pregnancy","volume":"67","author":"Doig","year":"1992","journal-title":"Br Heart J"},{"key":"10.1016\/j.ccl.2012.04.007_bib33","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0002-8703(05)80306-0","article-title":"Coadministration of flecainide acetate and sotalol during pregnancy: lack of teratogenic effects, passage across the placenta, and excretion in human breast milk","volume":"119","author":"Wagner","year":"1990","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2012.04.007_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/bmj.296.6617.249","article-title":"Maternal administration of flecainide to terminate and suppress fetal tachycardia","volume":"296","author":"Wren","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.ccl.2012.04.007_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/hrt.65.1.46","article-title":"Flecainide in the treatment of fetal tachycardias","volume":"65","author":"Allan","year":"1991","journal-title":"Br Heart J"},{"key":"10.1016\/j.ccl.2012.04.007_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-3476(05)80509-8","article-title":"Fetal supraventricular tachycardia treated with flecainide acetate","volume":"118","author":"Perry","year":"1991","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ccl.2012.04.007_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1297-9589(00)00003-5","article-title":"Fetal arrhythmias: diagnosis, prognosis, treatment; apropos of 33 cases","volume":"28","author":"Vautier-Rit","year":"2000","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.ccl.2012.04.007_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00002018-199920010-00008","article-title":"Treatment of cardiac arrhythmias during pregnancy: safety considerations","volume":"20","author":"Joglar","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.ccl.2012.04.007_bib39","series-title":"Cardiovascular pharmacotherapeutics","first-page":"57","article-title":"Alpha- and beta-adrenergic blocking drugs","author":"Frishman","year":"2011"},{"key":"10.1016\/j.ccl.2012.04.007_bib40","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1471-0528.1978.tb14909.x","article-title":"Propranolol for the treatment of hypertension in pregnancy","volume":"85","author":"Eliahou","year":"1978","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib41","first-page":"127","article-title":"Adrenergic beta-receptor blockers in hypertension of pregnancy","volume":"B1","author":"Sandstrom","year":"1982","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.ccl.2012.04.007_bib42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.CIR.97.5.451","article-title":"Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome","volume":"97","author":"Rashba","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2012.04.007_bib43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/00016349109007160","article-title":"Treatment of hyperthyroidism in pregnancy","volume":"70","author":"Sherif","year":"1991","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ccl.2012.04.007_bib44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/bmj.4.5626.281","article-title":"Management of pregnancy complicated by hypertrophic obstructive cardiomyopathy","volume":"4","author":"Turner","year":"1968","journal-title":"BMJ"},{"key":"10.1016\/j.ccl.2012.04.007_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0002-9149(78)90916-5","article-title":"Effect of propranolol on fetal tachycardia in diabetic pregnancy","volume":"42","author":"Teuscher","year":"1978","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2012.04.007_bib46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1471-0528.1980.tb04502.x","article-title":"Propranolol and hydralazine in the management of essential hypertension in pregnancy","volume":"87","author":"Bott-Kanner","year":"1980","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib47","series-title":"Cardiovascular pharmacotherapeutics","first-page":"1309","article-title":"Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation","author":"Ngo","year":"1997"},{"key":"10.1016\/j.ccl.2012.04.007_bib48","series-title":"Cardiac problems in pregnancy","first-page":"357","article-title":"The use of \u03b2-adrenergic blocking agents in pregnancy and lactation","author":"Hurst","year":"1998"},{"key":"10.1016\/j.ccl.2012.04.007_bib49","first-page":"341","article-title":"Propranolol in pregnancy: three year prospective study","volume":"2","author":"Livingstone","year":"1983","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.ccl.2012.04.007_bib50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/pgmj.57.669.427","article-title":"Antihypertensive therapy with propranolol during pregnancy and lactation","volume":"57","author":"Taylor","year":"1981","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ccl.2012.04.007_bib51","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0022-3476(75)80236-8","article-title":"Propranolol administration during pregnancy: effects on the fetus","volume":"86","author":"Gladstone","year":"1975","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ccl.2012.04.007_bib52","first-page":"792","article-title":"The effect of propranolol on the onset of breathing at birth","volume":"41","author":"Tunstall","year":"1969","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ccl.2012.04.007_bib53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0002-9378(79)90436-8","article-title":"Long-term propranolol therapy in pregnancy: maternal and fetal outcome","volume":"135","author":"Pruyn","year":"1979","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1471-0528.1991.tb13387.x","article-title":"The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment","volume":"98","author":"Blake","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00007691-198303000-00008","article-title":"Propranolol, propranolol glucuronide, and naphthoxylactic acid in breast milk and plasma","volume":"5","author":"Smith","year":"1983","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ccl.2012.04.007_bib56","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1471-0528.1980.tb04618.x","article-title":"Sotalol as a hypotensive agent in pregnancy","volume":"87","author":"O'Hare","year":"1980","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib57","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1651-2227.1998.tb01508.x","article-title":"Foetal supraventricular tachycardia treated with sotalol","volume":"87","author":"Sonesson","year":"1998","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ccl.2012.04.007_bib58","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0735-1097(99)00589-6","article-title":"Atrial flutter in the perinatal age group: diagnosis, management and outcome","volume":"35","author":"Lisowski","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2012.04.007_bib59","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0002-9149(85)90596-X","article-title":"Amiodarone in pregnancy","volume":"56","author":"Penn","year":"1985","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.ccl.2012.04.007_bib60","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/pd.1970120903","article-title":"Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome","volume":"12","author":"Valensise","year":"1992","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.ccl.2012.04.007_bib61","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/oxfordjournals.eurheartj.a062380","article-title":"Amiodarone during pregnancy","volume":"9","author":"Strunge","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2012.04.007_bib62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/pgmj.61.711.75","article-title":"Use of amiodarone during pregnancy","volume":"61","author":"Robson","year":"1985","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ccl.2012.04.007_bib63","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1651-2227.1988.tb10717.x","article-title":"Congenital hypothyroidism goiter and amiodarone","volume":"77","author":"DeWolf","year":"1988","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.ccl.2012.04.007_bib64","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/0002-8703(91)90489-5","article-title":"Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy","volume":"122","author":"Widerhorn","year":"1991","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2012.04.007_bib65","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0002-9149(87)91070-8","article-title":"Neonatal hypothyroidism after treatment by amiodarone during pregnancy","volume":"60","author":"Laurent","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2012.04.007_bib66","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0002-9378(95)91498-6","article-title":"Pregnancy outcome after gestational exposure to amiodarone in Canada","volume":"172","author":"Magee","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.ccl.2012.04.007_bib67","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/pd.1970140819","article-title":"Fetal hypothyroidism as a complication of amiodarone treatment of persistent fetal supraventricular tachycardia","volume":"14","author":"De Catte","year":"1994","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ccl.2012.04.007_bib68","series-title":"Cardiovascular pharmacotherapeutics","first-page":"99","article-title":"Calcium channel blockers","author":"Frishman","year":"2011"},{"key":"10.1016\/j.ccl.2012.04.007_bib69","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0196-0644(05)81615-4","article-title":"Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia","volume":"20","author":"Byerly","year":"1991","journal-title":"Ann Emerg Med"},{"issue":"Suppl 3","key":"10.1016\/j.ccl.2012.04.007_bib70","first-page":"16S","article-title":"Supraventricular tachycardia in pregnancy: cardioversion with verapamil","volume":"63","author":"Klein","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib71","first-page":"884","article-title":"Treatment of hypertension during pregnancy with the calcium antagonist verapamil","volume":"39","author":"Orlandi","year":"1986","journal-title":"Curr Therap Res"},{"key":"10.1016\/j.ccl.2012.04.007_bib72","first-page":"970","article-title":"Hemodynamic changes associated with intravenous infusion of the calcium antagonist verapamil in the treatment of severe gestational proteinuric hypertension","volume":"75","author":"Belfort","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib73","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcu.1870220506","article-title":"The effect of acute volume expansion and vasodilatation with verapamil on uterine and umbilical artery Doppler indices in severe preeclampsia","volume":"22","author":"Belfort","year":"1994","journal-title":"J\u00a0Clin Ultrasound"},{"key":"10.1016\/j.ccl.2012.04.007_bib74","first-page":"125","article-title":"Inhibition of myometrial hyperactivity by Ca antagonists","volume":"26","author":"Ulmsten","year":"1979","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.ccl.2012.04.007_bib75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000263745","article-title":"Hemodynamic changes during cardioversion in utero: a case report of supraventricular tachycardia and atrial flutter","volume":"8","author":"Kanzaki","year":"1993","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ccl.2012.04.007_bib76","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jcu.1870130406","article-title":"Treatment of fetal supraventricular tachyarrhythmias","volume":"13","author":"Kleinman","year":"1985","journal-title":"J\u00a0Clin Ultrasound"},{"key":"10.1016\/j.ccl.2012.04.007_bib77","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0002-9378(88)80015-2","article-title":"Tocolytic and cardiovascular effects of the calcium antagonist diltiazem in the near-term pregnant rabbit","volume":"159","author":"Holbrook","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ccl.2012.04.007_bib78","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1476-5381.1987.tb11271.x","article-title":"Diltiazem pharmacokinetics in the rat and relationship between its serum concentration and uterine and cardiovascular effects","volume":"91","author":"Downing","year":"1987","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ccl.2012.04.007_bib79","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00006250-199404000-00024","article-title":"Nifedipine and its indications in obstetrics and gynecology","volume":"83","author":"Childress","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib80","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/0002-9149(93)90590-9","article-title":"Successful management of labor and delivery in primary pulmonary hypertension","volume":"71","author":"Nootens","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2012.04.007_bib81","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00006250-199011000-00016","article-title":"Single dose of nifedipine in normotensive pregnancy: nifedipine concentrations, hemodynamic responses, and uterine and fetal flow velocity waveform","volume":"76","author":"Pirhonen","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib82","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000299294","article-title":"Comparison of the effects of nicardipine and nifedipine on isolated human myometrium","volume":"16","author":"Maigaard","year":"1983","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ccl.2012.04.007_bib83","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0735-6757(92)90181-V","article-title":"Adenosine use in pregnancy: lack of effect on fetal heart rate","volume":"10","author":"Leffler","year":"1992","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ccl.2012.04.007_bib84","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mob.2000.107928","article-title":"Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy","volume":"183","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib85","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1524-6175.2001.00456.x","article-title":"Management of hypertension in pregnancy","volume":"3","author":"Lenfant","year":"2001","journal-title":"J\u00a0Clin Hypertens"},{"key":"10.1016\/j.ccl.2012.04.007_bib86","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2012.04.007_bib87","first-page":"124","article-title":"Pharmacologic approaches for the management of systemic hypertension in pregnancy","volume":"2","author":"Awad","year":"2000","journal-title":"Heart Dis"},{"key":"10.1016\/j.ccl.2012.04.007_bib88","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1479-828X.2000.tb01136.x","article-title":"The\u00a0detection, investigation and management of hypertension in pregnancy: executive summary. Consensus statement from the Australasian Society for the Study of Hypertension in Pregnancy","volume":"40","author":"Brown","year":"2000","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib89","first-page":"1245","article-title":"Report of the\u00a0Canadian Hypertension Society consensus conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy","volume":"157","author":"Rey","year":"1997","journal-title":"CMAJ"},{"key":"10.1016\/j.ccl.2012.04.007_bib90","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJM197608052950606","article-title":"Drug therapy: hydralazine","volume":"295","author":"Koch-Weser","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2012.04.007_bib91","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0095-5108(18)30853-4","article-title":"Antihypertensive drugs in pregnancy","volume":"12","author":"Naden","year":"1985","journal-title":"Clin Perinatol"},{"issue":"Supp 2","key":"10.1016\/j.ccl.2012.04.007_bib92","doi-asserted-by":"crossref","first-page":"211S","DOI":"10.1111\/j.1365-2125.1979.tb04783.x","article-title":"Use of labetalol in the treatment of severe hypertension during pregnancy","volume":"8","author":"Michael","year":"1979","journal-title":"Br J Clin Pharmacol"},{"issue":"Supp 2","key":"10.1016\/j.ccl.2012.04.007_bib93","doi-asserted-by":"crossref","first-page":"217S","DOI":"10.1111\/j.1365-2125.1979.tb04784.x","article-title":"Use of labetalol and methyldopa in pregnancy induced hypertension","volume":"8","author":"Lamming","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ccl.2012.04.007_bib94","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1471-0528.1992.tb13698.x","article-title":"A\u00a0randomized placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension","volume":"99","author":"Pickles","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib95","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00016349209007974","article-title":"Fetal death following labetalol administration in preeclampsia","volume":"71","author":"Olsen","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ccl.2012.04.007_bib96","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1651-2227.1989.tb11183.x","article-title":"Severe adverse effects of maternal labetalol in a premature infant","volume":"78","author":"Haraldsson","year":"1989","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.ccl.2012.04.007_bib97","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1089\/thy.1998.8.795","article-title":"Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis","volume":"8","author":"Bowman","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.ccl.2012.04.007_bib98","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0020-7292(95)02351-C","article-title":"Labetalol vs. methyldopa in the treatment of pregnancy-induced hypertension","volume":"49","author":"el-Qarmalawi","year":"1995","journal-title":"Int J Gynaecol Obstet"},{"issue":"Suppl 3","key":"10.1016\/j.ccl.2012.04.007_bib99","first-page":"168","article-title":"Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared","volume":"59","author":"Walker","year":"1983","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ccl.2012.04.007_bib100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0310057X8401200412","article-title":"Sodium nitroprusside, pregnancy, and multiple intracranial aneurysms","volume":"12","author":"Willoughby","year":"1984","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.ccl.2012.04.007_bib101","first-page":"72","article-title":"Clinical report of the use of sodium nitroprusside in severe preeclampsia","volume":"3","author":"Paull","year":"1975","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.ccl.2012.04.007_bib102","first-page":"533","article-title":"Use of sodium nitroprusside in complications of gestational hypertension","volume":"60","author":"Stempel","year":"1982","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib103","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/0002-9378(82)90007-2","article-title":"Fetal and maternal effects of sodium nitroprusside used to counteract hypertension in gravid ewes","volume":"143","author":"Ellis","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib104","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0002-9378(81)90960-1","article-title":"Nitroprusside induced hemodynamic alteration in normotensive and hypertensive pregnant sheep","volume":"139","author":"Lieb","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib105","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/0002-9378(81)90492-0","article-title":"Fetal toxicity of nitroprusside in the pregnant ewe","volume":"139","author":"Naulty","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib106","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00000542-198509000-00019","article-title":"The use of nitroglycerin in preventing the hypertensive response to tracheal intubation in severe preeclamptics","volume":"63","author":"Hood","year":"1985","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ccl.2012.04.007_bib107","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00000542-198907000-00039","article-title":"Intravenous nitroglycerin for uterine relaxation in the post partum patient with retained placenta","volume":"71","author":"Peng","year":"1989","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ccl.2012.04.007_bib108","first-page":"23","article-title":"Acute myocardial infarction in pregnancy","volume":"15","author":"Fasseas","year":"1998","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.ccl.2012.04.007_bib109","series-title":"Cardiac problems in pregnancy","first-page":"391","article-title":"Use of vasodilators during pregnancy","author":"Calvin","year":"1998"},{"key":"10.1016\/j.ccl.2012.04.007_bib110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.jp.7200303","article-title":"Nitroglycerin for rapid tocolysis: development of a protocol and a literature review","volume":"20","author":"O'Grady","year":"2000","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.ccl.2012.04.007_bib111","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)08049-0","article-title":"Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis","volume":"355","author":"von Dadelszen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2012.04.007_bib112","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1524-6175.2007.06695.x","article-title":"Hypertensive pregnancy disorders: current concept","volume":"9","author":"Wagner","year":"2007","journal-title":"J\u00a0Clin Hypertens"},{"key":"10.1016\/j.ccl.2012.04.007_bib113","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1751-7176.2009.00085.x","article-title":"ASH position paper: hypertension in pregnancy","volume":"11","author":"Lindheimer","year":"2009","journal-title":"J\u00a0Clin Hypertens"},{"key":"10.1016\/j.ccl.2012.04.007_bib114","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.298.13.1566","article-title":"Caring for women with hypertension in pregnancy","volume":"298","author":"Sibai","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2012.04.007_bib115","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMcp0804872","article-title":"Chronic hypertension in pregnancy","volume":"365","author":"Seely","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2012.04.007_bib116","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(99)00288-3","article-title":"Material blood pressure and birthweight","volume":"355","author":"deSwiet","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2012.04.007_bib117","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/bmj.318.7194.1332","article-title":"Management of hypertension in pregnancy","volume":"318","author":"Magee","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.ccl.2012.04.007_bib118","first-page":"634","article-title":"Clonidine hydrochloride - a safe and effective antihypertensive agent in pregnancy","volume":"66","author":"Horvath","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib119","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(80)91723-7","article-title":"Possible risk with captopril during pregnancy: some animal data","volume":"2","author":"Pipkin","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2012.04.007_bib120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1113\/jphysiol.1982.sp014081","article-title":"The effect of captopril (SQ 14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit","volume":"323","author":"Broughton-Pipkin","year":"1982","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.ccl.2012.04.007_bib121","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1172\/JCI110834","article-title":"Effect of captopril on uterine\u00a0blood flow and prostaglandin E synthesis in the pregnant rabbit","volume":"71","author":"Ferris","year":"1982","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ccl.2012.04.007_bib122","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3181\/00379727-170-41446","article-title":"Captopril: association with fetal death and pulmonary vascular changes in the rabbit (41446)","volume":"170","author":"Keith","year":"1982","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.ccl.2012.04.007_bib123","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1476-5381.1986.tb10195.x","article-title":"The effect of enalapril (MK-421), an angiotensin-converting enzyme inhibitor, on the conscious pregnant ewe and her foetus","volume":"87","author":"Broughton-Pipkin","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ccl.2012.04.007_bib124","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0272-0590(90)90250-N","article-title":"Maternotoxicity and fetotoxicity of an angiotensin-converting enzyme inhibitor, enalapril, in rabbits","volume":"14","author":"Minsker","year":"1990","journal-title":"Fundam Appl Toxicol"},{"key":"10.1016\/j.ccl.2012.04.007_bib125","first-page":"96","article-title":"Angiotensin-converting enzyme inhibitors in pregnancy","volume":"2","author":"Broughton-Pipkin","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2012.04.007_bib126","first-page":"805","article-title":"Fetal abnormalities associated with the use of captopril during pregnancy","volume":"60","author":"Duminy","year":"1982","journal-title":"S\u00a0Afr Med J"},{"key":"10.1016\/j.ccl.2012.04.007_bib127","first-page":"133","article-title":"Persistent anuria in neonate: a side effect of captopril","volume":"2","author":"Guignard","year":"1981","journal-title":"Int J Pediatr Nephrol"},{"key":"10.1016\/j.ccl.2012.04.007_bib128","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(84)91581-2","article-title":"Captopril during pregnancy","volume":"2","author":"Fiocchi","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2012.04.007_bib129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM198509123131107","article-title":"Hypertension in pregnancy (current concepts)","volume":"313","author":"Lindheimer","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2012.04.007_bib130","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.267.18.2445","article-title":"Warning on the use of ACE inhibitors in second and third trimester of pregnancy","volume":"267","author":"Nightingale","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2012.04.007_bib131","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0002-9343(94)90172-4","article-title":"Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use","volume":"96","author":"Shotan","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.ccl.2012.04.007_bib132","series-title":"Cardiac problems in pregnancy","first-page":"351","article-title":"Diuretics in pregnancy","author":"Cohen","year":"1998"},{"key":"10.1016\/j.ccl.2012.04.007_bib133","unstructured":"Drug Information for the Health Care Professional, USP DI, vol. 1, 16th edition. Rockville (MD): United States Pharmacopeial Convention; 1996."},{"key":"10.1016\/j.ccl.2012.04.007_bib134","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/CRD.0b013e31822b4939","article-title":"Acetazolamide: a forgotten diuretic agent","volume":"19","author":"Kassamali","year":"2011","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.ccl.2012.04.007_bib135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0028-2243(90)90146-R","article-title":"Possible association between acetazolamide administration during pregnancy and metabolic disorders in the newborn","volume":"35","author":"Merlob","year":"1990","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl","key":"10.1016\/j.ccl.2012.04.007_bib136","first-page":"15s","article-title":"Metastatic pheochromocytoma in pregnancy and fetal biophysical assessment after maternal administration of alpha-adrenergic, beta-adrenergic, and dopamine antagonist","volume":"68","author":"Devoe","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib137","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2125.1983.tb02213.x","article-title":"Clinical pharmacological studies with prazosin during pregnancy complicated by hypertension","volume":"16","author":"Rubin","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ccl.2012.04.007_bib138","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/11632010-000000000-00000","article-title":"Statins and pregnancy. Between supposed risks and theoretical benefits","volume":"72","author":"Lecarpentier","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.ccl.2012.04.007_bib139","series-title":"Cardiac problems in pregnancy","first-page":"445","article-title":"Lipid-lowering drugs in pregnancy and lactation","author":"Cox","year":"1998"},{"key":"10.1016\/j.ccl.2012.04.007_bib140","first-page":"1343","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2012.04.007_bib141","series-title":"Cardiovascular pharmacotherapeutics","first-page":"323","article-title":"Lipid-lowering drugs","author":"Frishman","year":"2011"},{"key":"10.1016\/j.ccl.2012.04.007_bib142","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0002-9343(80)90181-3","article-title":"Maternal and fetal sequelae of anticoagulation during pregnancy","volume":"68","author":"Hall","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.ccl.2012.04.007_bib143","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0038-1646558","article-title":"Risks to the fetus of anticoagulant therapy during pregnancy","volume":"61","author":"Ginsberg","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ccl.2012.04.007_bib144","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0002-9378(89)90535-8","article-title":"Thrombosis prophylaxis in pregnancy with use of subcutaneous heparin adjusted by monitoring heparin concentration in plasma","volume":"161","author":"Dahlman","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib145","doi-asserted-by":"crossref","first-page":"122s","DOI":"10.1378\/chest.119.1_suppl.122S","article-title":"Use of antithrombotic agents during pregnancy","volume":"119","author":"Ginsberg","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ccl.2012.04.007_bib146","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0038-1651102","article-title":"Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy","volume":"57","author":"Forestier","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ccl.2012.04.007_bib147","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2141.1985.tb02969.x","article-title":"Placental transport of low molecular weight heparin in the pregnant sheep","volume":"59","author":"Andrew","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ccl.2012.04.007_bib148","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0022-3476(75)80986-3","article-title":"Congenital malformations associated with the administration of oral anticoagulants during pregnancy","volume":"86","author":"Pettifor","year":"1975","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ccl.2012.04.007_bib149","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0735-1097(99)00044-3","article-title":"Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves","volume":"33","author":"Vitale","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2012.04.007_bib150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/(SICI)1096-8628(19970905)71:4<391::AID-AJMG4>3.0.CO;2-X","article-title":"Severe cervical dysplasia and nasal cartilage calcification following prenatal warfarin exposure","volume":"71","author":"Howe","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ccl.2012.04.007_bib151","first-page":"1354","article-title":"Probable vitamin K dependence of gamma-carboxyglutamate formation in bone","volume":"35","author":"Haushka","year":"1976","journal-title":"Fed Proc"},{"key":"10.1016\/j.ccl.2012.04.007_bib152","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(76)92804-X","article-title":"Warfarin and fetal abnormality","volume":"1","author":"Sherman","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2012.04.007_bib153","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0140-6736(76)90587-0","article-title":"Warfarin-induced fetal abnormalities","volume":"2","author":"Holzgreve","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2012.04.007_bib154","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0378-3782(94)90221-6","article-title":"Late neurological, cognitive and behavioral sequelae of prenatal exposure to coumarins: a pilot study","volume":"38","author":"Olthof","year":"1994","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ccl.2012.04.007_bib155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/hrt.82.1.23","article-title":"Anticoagulation in pregnant women with mechanical heart valve prostheses","volume":"82","author":"Meschengieser","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.ccl.2012.04.007_bib156","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/hrt.71.2.196","article-title":"Outcome of pregnancy in women with valve prostheses","volume":"71","author":"Sbarouni","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.ccl.2012.04.007_bib157","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/0735-1097(96)00072-1","article-title":"Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prosthesis","volume":"27","author":"Salazar","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2012.04.007_bib158","series-title":"Cardiac problems in pregnancy","first-page":"407","article-title":"Anticoagulation in pregnancy","author":"McGehee","year":"1998"},{"issue":"Suppl S1","key":"10.1016\/j.ccl.2012.04.007_bib159","first-page":"105","article-title":"What is the optimal management of pregnant women with valvular heart disease in\u00a0pregnancy?","volume":"29","author":"Chan","year":"1999","journal-title":"Haemostasis"},{"key":"10.1016\/j.ccl.2012.04.007_bib160","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","article-title":"A\u00a0comparison of aspirin with placebo after heart valve replacement","volume":"329","author":"Turpie","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2012.04.007_bib161","series-title":"Cardiovascular pharmacotherapeutics","article-title":"Antiplatelet and other antithrombotic drugs","author":"Frishman","year":"2011"},{"key":"10.1016\/j.ccl.2012.04.007_bib162","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jama.1991.03470020086038","article-title":"A\u00a0meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease","volume":"266","author":"Imperiale","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2012.04.007_bib163","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low dose aspirin for the prevention and treatment of pre-eclampsia among 9,364 pregnant women (CLASP: Collaborative Low Dose Aspirin Study in Pregnancy)","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2012.04.007_bib164","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/0002-9378(90)90706-D","article-title":"Emergency treatment with recombinant tissue plasminogen activator of pulmonary embolism in a pregnant woman with AT III deficiency","volume":"163","author":"Baudo","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ccl.2012.04.007_bib165","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/BF01711225","article-title":"Successful treatment of massive pulmonary embolism with recombinant tissue plasminogen activator in a pregnant woman with intact gravidity and preterm labour","volume":"16","author":"Flossdorf","year":"1990","journal-title":"Intensive Care Med"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865112000586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865112000586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T19:14:31Z","timestamp":1713986071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865112000586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":165,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0733865112000586"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2012.04.007","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}